Business
PharmaResearch Spin-Off into Holding and Aesthetics Companies Approved by Board of Directors
PharmaResearch announced on June 13 that its board of directors has approved a corporate spin-off, resulting in the formation of two distinct entities: PharmaResearch Holdings, which will remain as the surviving entity focused on investment and governance, and PharmaResearch, a newly established operating company that will continue to lead the aesthetics business.
About this update from Pharmaresearch Co., Ltd.
[{"type":"text","content":"SEONGNAM, South Korea, June 13, 2025 /PRNewswire/ -- PharmaResearch announced on June 13 that its board of directors has approved a corporate spin-off, resulting in the formation of two distinct entities: PharmaResearch Holdings, which will remain as the surviving entity focused on investment and governance, and PharmaResearch, a newly established operating company that will continue to lead the aesthetics business.","length":419,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":104,"url":"https://media.zenfs.com/en/prnewswire.com/9d295cf84a1ba3def3a878e92749c2c8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rrKdtV0hIXsOjyxhhZlBNg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4MztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9d295cf84a1ba3def3a878e92749c2c8","width":400,"height":104}},"href":"https://mma.prnewswire.com/media/2710342/CI_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The decision is part of a broader strategy to enhance operational efficiency and sharpen business focus by separating investment and commercial functions. PharmaResearch Holdings will serve as the group's control tower, managing subsidiaries, directing M&A activities, and pursuing long-term value creation. The new PharmaResearch will concentrate on its core business areas—including medical devices, pharmaceuticals, and cosmetics—with the goal of accelerating growth in the global aesthetics market.","length":510,"tagName":"p"},{"type":"text","content":"The spin-off ratio is 0.7427944 for PharmaResearch Holdings and 0.2572056 for the new PharmaResearch. Following the spin-off, total assets are expected to reach KRW 580.2 billion (approx. USD 427.2 million) for PharmaResearch Holdings and KRW 219.5 billion (approx. USD 161.6 million) for PharmaResearch.","length":304,"tagName":"p"},{"type":"text","content":"The proposed spin-off will be finalized following shareholder approval at an extraordinary general meeting scheduled for October. If approved, the effective date will be November 1, 2025, followed by re-listing procedures for both entities.","length":245,"tagName":"p"},{"type":"text","content":"A company spokesperson commented, "This spin-off will allow us to sharpen our competitive ...